How much funding has Aria Diagnostics raised?

Aria Diagnostics has raised $52.7M in total funding, most recently a Series C round.

Who are Aria Diagnostics's investors?

Aria Diagnostics's investors include Meritech Capital Partners.

When was Aria Diagnostics founded?

Aria Diagnostics was founded in 2010.

Where is Aria Diagnostics headquartered?

Aria Diagnostics is headquartered in San Jose, California, United States.

What industry is Aria Diagnostics in?

Aria Diagnostics operates in Healthcare, Diagnostics.

Aria Diagnostics

Acquired

San Jose, United States · Founded 2010 · $52.7M raised

Healthcare

Diagnostics

Headquarters: San Jose, California
Founded: 2010
Business Model: B2B
Website: ariosadx.com

Total Funding: $52.7M
Last Round: $52.7M Series CJan 2012
Rounds: 1

About

Aria Diagnostics (later renamed Ariosa Diagnostics) was a San Jose-based molecular diagnostics company that developed the Harmony Prenatal Test, a non-invasive prenatal test using cell-free DNA analysis to screen for chromosomal abnormalities. Founded in 2010 and emerged from stealth in January 2012, the company was acquired by Roche in January 2015.

Summary

Aria Diagnostics is a Healthcare company based in San Jose, United States, founded in 2010. It has raised $52.7M in total across 1 round, most recently a $52.7M Series C round in Jan 2012. Investors include Meritech Capital Partners.